Sabero Organics Gujarat Ltd(Merged)
Sabero Organics Gujarat Limited,Incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in manufacture and sell Crop Protection Chemicals.
- Market Cap ₹ Cr.
- Current Price ₹ 175
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 37.7
- Dividend Yield 0.00 %
- ROCE 16.6 %
- ROE 37.3 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 4.64 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of -7.73% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
138 | 154 | 195 | 364 | 427 | 411 | 358 | 515 | 720 | 809 | |
123 | 137 | 170 | 314 | 345 | 372 | 395 | 465 | 643 | 726 | |
Operating Profit | 14 | 17 | 25 | 51 | 82 | 39 | -37 | 50 | 77 | 83 |
OPM % | 10% | 11% | 13% | 14% | 19% | 9% | -10% | 10% | 11% | 10% |
0 | 2 | 2 | 2 | 3 | 3 | 3 | -1 | 1 | 1 | |
Interest | 9 | 12 | 15 | 17 | 17 | 15 | 29 | 30 | 30 | 27 |
Depreciation | 5 | 5 | 5 | 6 | 7 | 9 | 11 | 11 | 13 | 14 |
Profit before tax | 1 | 1 | 7 | 30 | 61 | 17 | -75 | 8 | 35 | 43 |
Tax % | 78% | 70% | 28% | 27% | 37% | 39% | -18% | 1% | 5% | |
0 | 0 | 5 | 22 | 39 | 11 | -61 | 8 | 33 | 29 | |
EPS in Rs | 0.15 | 1.67 | 7.46 | 11.45 | 3.14 | -18.06 | 2.28 | 9.77 | 8.59 | |
Dividend Payout % | 0% | 0% | 0% | 0% | 10% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 21% |
TTM: | 25% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 9% |
3 Years: | 46% |
TTM: | -9% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | -8% |
Last Year: | 37% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 25 | 27 | 29 | 29 | 34 | 34 | 34 | 34 | 34 |
Reserves | 15 | 16 | 22 | 44 | 81 | 92 | 31 | 38 | 72 |
60 | 62 | 52 | 76 | 81 | 164 | 218 | 289 | 322 | |
37 | 44 | 61 | 106 | 90 | 93 | 117 | 157 | 156 | |
Total Liabilities | 138 | 150 | 164 | 254 | 286 | 383 | 399 | 517 | 583 |
61 | 60 | 58 | 89 | 92 | 116 | 120 | 147 | 159 | |
CWIP | 0 | 0 | 1 | 2 | 3 | 15 | 46 | 43 | 47 |
Investments | 0 | 0 | 0 | 1 | 1 | 3 | 8 | 8 | 9 |
76 | 90 | 104 | 162 | 190 | 250 | 225 | 319 | 368 | |
Total Assets | 138 | 150 | 164 | 254 | 286 | 383 | 399 | 517 | 583 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
-4 | 15 | 32 | 36 | 12 | 8 | 8 | -19 | 8 | |
-4 | -4 | -5 | -38 | -9 | -61 | -61 | -24 | -19 | |
9 | -10 | -23 | 7 | -3 | 33 | 33 | 40 | 11 | |
Net Cash Flow | 1 | 2 | 4 | 5 | -0 | -21 | -21 | -2 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 51 | 42 | 51 | 55 | 64 | 68 | 74 | 105 | 101 |
Inventory Days | 147 | 171 | 113 | 72 | 80 | 105 | 91 | 97 | 61 |
Days Payable | 118 | 141 | 146 | 127 | 93 | 86 | 159 | 160 | 114 |
Cash Conversion Cycle | 80 | 72 | 18 | -1 | 51 | 87 | 5 | 41 | 48 |
Working Capital Days | 93 | 94 | 64 | 44 | 79 | 112 | 72 | 97 | 97 |
ROCE % | 13% | 21% | 37% | 45% | 14% | -16% | 12% | 17% |
Documents
Announcements
No data available.